One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate.
Marks
Lawrence B
LB
Zeng
Jing
J
Prosnitz
Leonard R
LR
D001943:Breast Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D018275:Carcinoma, Lobular / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D005260:Female; D006801:Humans; D016015:Logistic Models; D008207:Lymphatic Metastasis; D008408:Mastectomy; D015412:Mastectomy, Segmental; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D049451:Nomograms; D018579:Patient Selection; D011237:Predictive Value of Tests; D012372:ROC Curve; D018714:Radiotherapy, Adjuvant; D015203:Reproducibility of Results; D012107:Research Design; D018570:Risk Assessment; D012307:Risk Factors; D021701:Sentinel Lymph Node Biopsy; D016896:Treatment Outcome